BIOVAIL ANNOUNCES CHANGES TO ORGANIZATIONAL STRUCTURE; COMPANY REALIGNED INTO THREE BUSINESS UNITS

Biovail Corporation today announced changes to its business infrastructure that will further enable the Company to create, maintain and extend competitive advantage in the key markets for which it produces medicines. Effective immediately, Biovail has reorganized its business into three distinct Business Units -- Biovail Drug Delivery (BDD), which comprises Biovail's drug-delivery technologies, its drug-development capabilities and its strategic partnerships; Biovail Pharmaceuticals U.S. (BPUS), which focuses on the promotion of products to specialists in niche therapeutic markets; and Biovail Pharmaceuticals Canada (BPC), the Company's Canadian business unit which promotes products to both to specialist and primary-care physicians in Canada.

CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=583286)